You are here

PRX-102

Chiesi Fabry disease treatment gets EU marketing authorization

Labiotech.eu

Wed, 05/10/23 - 10:06 am

Protalix BioTherapeutics

Protalix eyes Fabry drug resubmission thanks to multiple phase 3 readouts

Fierce Biotech

Sun, 03/20/22 - 11:05 pm

Protalix BioTherapeutics

clinical trials

Protalix's Fabry Disease Treatment Hits the Mark in Phase III Switch-Over Study

BioSpace

Thu, 12/31/20 - 12:01 pm

Protalix BioTherapeutics

clinical trials

Protalix Plans Human Clinical Tests of Medication for Rare Fabry's Disease

Bloomberg

Thu, 03/24/11 - 03:00 pm

Protalix BioTherapeutics

Fabry's disease

rheumatoid arthritis